Insiders Buy as Sellers Cash Out Globally
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
The most notable open-market buy in the latest filing data came from UBER. Andrew Gordon MacDonald, President and COO, filed on September 8 that he purchased 54,325 shares for roughly $4.1 million on September 4. That is a discretionary, open-market buy from a serving C-level executive, the strongest signal category. Uber's short interest sits at just 2.4% of free float, so this is a confidence trade, not a squeeze story.
At the other end of the ledger, the CEO of South Korean robotics firm ROBOTIS filed a $75 million sale of shares on September 8 itself. Kim Byeong Soo offloaded 366,525 shares. That is a large disposal relative to the company's size and worth watching for follow-on filings.
In India, Fosun Pharma Industrial cut its stake in Gland Pharma twice in the same filing window, selling a combined $296 million worth of shares across two transactions. That scale of promoter selling is a meaningful overhang signal.
Private equity firm L Catterton sold $94 million of shares in Italian cosmetics maker Intercos, filed on September 8. PE exits of this size typically signal a distribution phase after a holding period.
On the buy side, the chairman of Turkish industrial firm Burçelik Vana stepped in with a $12.9 million personal purchase on September 7, the same day an asset manager sold a similar sized block. That simultaneous insider buy against institutional selling is an unusual pattern.
Note: US SEC EDGAR Form 4 tables were not available in this environment. The trades above come from ORTEX's global vendor insider dataset, latest filing date September 8, 2026.
Stocks in this article
How this article was generated
- Generated
- 21 Oct 2026, 12:13
- Prompt version
- v1.0
- Data sources
- Institutional positioningAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.